AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2881574 — intervention group
Group type: COMPARATOR
Intervention: Org 2305 30 mg (O 30)
Number of subjects: 15
Study 2881574 — intervention group
Group type: EXPERIMENTAL
Intervention: Org 2305 60 mg (O 60)
Number of subjects: 15
Study 2881574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 15 mg (DZ)
Number of subjects: 15
Study 2881574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30285177 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 321
Study 30285177 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 321
Study 30285177 — intervention group
Group type: EXPERIMENTAL
Intervention: APM
Number of subjects: 321
Study 30285177 — intervention group
Group type: COMPARATOR
Intervention: PT
Number of subjects: 321
Study 26259568 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive bi-directional remote monitoring system (Motiva®)
Number of subjects: 621
Study 26259568 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 621
Study 23622766 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 25
Study 23622766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 21940598 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 90
Study 21940598 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 90
Study 21940598 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 90
Study 21940598 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 90
Study 18463885 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment started within the first hour after AAT (Group A, 20 patients)
Number of subjects: 52
Study 18463885 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment started more than 1 hour later and less than 16 hours after AAT (Group B, 17 patients)
Number of subjects: 52
Study 18463885 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment started after 24 hours or more (Group C, 15 patients)
Number of subjects: 52
Study 16612257 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake of 350 mmol/day
Number of subjects: 11
Study 16612257 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake of 50 mmol/day
Number of subjects: 11
Study 16612257 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril administration for 3 days
Number of subjects: 11
Study 16612257 — intervention group
Group type: COMPARATOR
Intervention: Control group with essential hypertension
Number of subjects: 11
Study 14640502 — intervention group
Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant
Number of subjects: 492
Study 14640502 — intervention group
Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant plus vessel
Number of subjects: 492
Study 14640502 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleach
Number of subjects: 492
Study 14640502 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleach plus vessel
Number of subjects: 492
Study 14640502 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 492
Study 10769011 — intervention group
Group type: EXPERIMENTAL
Intervention: GI5402
Number of subjects: 0
Study 8634010 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients
Number of subjects: 20
Study 8634010 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients with low frequency of panic attacks
Number of subjects: 20
Study 8634010 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients with high frequency of panic attacks
Number of subjects: 20
Study 8634010 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 20
Study 1345129 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape instruction and feedback (videotherapy)
Number of subjects: 31
Study 1345129 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 31
Study 3870921 — intervention group
Group type: EXPERIMENTAL
Intervention: Appointment reminder cards and telephone calls to reschedule missed appointments
Number of subjects: 973
Study 3870921 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control group
Number of subjects: 973
Study 30445644 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-play intervention allowing unrestricted access to outdoor areas for active play.
Number of subjects: 231
Study 30445644 — intervention group
Group type: COMPARATOR
Intervention: Control group with usual scheduled periods of outdoor play.
Number of subjects: 231
Study 30066385 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine pre-loading (4 weeks of 21 mg nicotine patch use prior to quitting)
Number of subjects: 1792
Study 30066385 — intervention group
Group type: COMPARATOR
Intervention: Standard smoking cessation medications with behavioral support
Number of subjects: 1792
Study 27213492 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Addiction Treatment (MBAT)
Number of subjects: 412
Study 27213492 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 412
Study 27213492 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 412
Study 25265494 — intervention group
Group type: EXPERIMENTAL
Intervention: vemurafenib and cobimetinib (combination group)
Number of subjects: 495
Study 25265494 — intervention group
Group type: COMPARATOR
Intervention: vemurafenib and placebo (control group)
Number of subjects: 495
Study 22795495 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring (food journal completion)
Number of subjects: 123
Study 22795495 — intervention group
Group type: EXPERIMENTAL
Intervention: Skipping meals
Number of subjects: 123
Study 22795495 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating out for lunch (at least once a week)
Number of subjects: 123
Study 20635018 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed sheet (full disclosure of risks)
Number of subjects: 106
Study 20635018 — intervention group
Group type: COMPARATOR
Intervention: Brief sheet (brief information on procedure-related risks)
Number of subjects: 106
Study 18204391 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard NSAIDs
Number of subjects: 0
Study 18204391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox-2 NSAIDs
Number of subjects: 0
Study 18204391 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0
Study 18204391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization
Number of subjects: 0
Study 18204391 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 0
Study 18204391 — intervention group
Group type: COMPARATOR
Intervention: Baseline model
Number of subjects: 0
Study 18204391 — intervention group
Group type: COMPARATOR
Intervention: Second model with effectiveness data
Number of subjects: 0
Study 15878289 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-leg semisquat exercise with maximum hip adduction isometric contraction (DLSS-HA)
Number of subjects: 20
Study 15878289 — intervention group
Group type: COMPARATOR
Intervention: Double-leg semisquat exercise without hip adduction (DLSS)
Number of subjects: 20
Study 11961033 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased peritoneal clearance of small solutes to adequacy targets recommended by KDOQI
Number of subjects: 0
Study 11961033 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard peritoneal clearance)
Number of subjects: 0
Study 10517693 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% hydrocortisone butyrate in an oil-in-water emulsion (Locoid Crelo)
Number of subjects: 0
Study 10517693 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone 17-21 dipropionate lotion (Diprosone lotion)
Number of subjects: 0
Study 7747540 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporin 5 mg/kg/day
Number of subjects: 60
Study 7747540 — intervention group
Group type: COMPARATOR
Intervention: Topical dithranol and ultraviolet B therapy
Number of subjects: 60
Study 1443489 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient controlled analgesia machine feedback signaling only successful demands
Number of subjects: 0
Study 1443489 — intervention group
Group type: COMPARATOR
Intervention: Patient controlled analgesia machine feedback acknowledging every demand
Number of subjects: 0
Study 3083829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (2 X 150 mg/d)
Number of subjects: 0
Study 3083829 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (4 X 50 micrograms/d and 4 X 200 micrograms/d)
Number of subjects: 0
Study 3083829 — intervention group
Group type: EXPERIMENTAL
Intervention: Rioprostil (3 X 100 micrograms/d)
Number of subjects: 0
Study 3083829 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (5 mg and 10 mg/d)
Number of subjects: 0
Study 3083829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (2 X 25 mg/d)
Number of subjects: 0
Study 30413972 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Water Fluoridation (CWF)
Number of subjects: 474
Study 30261031 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized palliative care intervention
Number of subjects: 18
Study 30261031 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving specialized palliative care intervention)
Number of subjects: 18
Study 27531110 — intervention group
Group type: EXPERIMENTAL
Intervention: CSCLR (coaxially sighted corneal light reflex)
Number of subjects: 420
Study 27531110 — intervention group
Group type: COMPARATOR
Intervention: LOS (line of sight)
Number of subjects: 420
Study 27531110 — intervention group
Group type: EXPERIMENTAL
Intervention: CSCLR
Number of subjects: 420
Study 27531110 — intervention group
Group type: COMPARATOR
Intervention: LOS
Number of subjects: 420
Study 25135997 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab treatment with vitamin D levels ≤ 8 ng/mL
Number of subjects: 422
Study 25135997 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab treatment with vitamin D levels > 8 ng/mL
Number of subjects: 422
Study 25135997 — intervention group
Group type: COMPARATOR
Intervention: Rituximab treatment without vitamin D deficiency (levels ≤ 8 ng/mL or > 8 ng/mL)
Number of subjects: 422
Study 25135997 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D substitution in individuals with VDD
Number of subjects: 422
Study 22751518 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative performance ratings (OPRs) by blinded expert judges
Number of subjects: 8
Study 22751518 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervising surgeon ratings
Number of subjects: 8
Study 22751518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrater agreement among expert judges
Number of subjects: 8
Study 22751518 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of local and national norms for interpretation of OPRs
Number of subjects: 8
Study 20478056 — intervention group
Group type: EXPERIMENTAL
Intervention: CHEST PAIN CHOICE
Number of subjects: 0
Study 20478056 — intervention group
Group type: COMPARATOR
Intervention: Usual ED care
Number of subjects: 0
Study 19045974 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 101
Study 19045974 — intervention group
Group type: COMPARATOR
Intervention: Community Treatment by Experts (CTBE)
Number of subjects: 101
Study 15924587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (EZE) 10 mg
Number of subjects: 450
Study 15924587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 450
Study 15924587 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (EZE) co-administered with atorvastatin (ATV)
Number of subjects: 450
Study 12803814 — intervention group
Group type: EXPERIMENTAL
Intervention: Erroneous verbalizations by an accomplice
Number of subjects: 32
Study 12803814 — intervention group
Group type: COMPARATOR
Intervention: Adequate thoughts verbalized by an accomplice
Number of subjects: 32
Study 12803814 — intervention group
Group type: COMPARATOR
Intervention: No verbalizations by an accomplice
Number of subjects: 32
Study 9702082 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse transcriptase polymerase chain reaction (RT-PCR)
Number of subjects: 20
Study 7956631 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 102
Study 7956631 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 102
Study 3291601 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum added to the usual diet four times per day for 4 weeks
Number of subjects: 9
Study 3291601 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to the usual diet four times per day for 4 weeks
Number of subjects: 9
Study 31168711 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight sessions of moderate intensity aerobic exercise along with eight self-management modules during chemotherapy.
Number of subjects: 26
Study 31168711 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 26
Study 29683702 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (PE) alone
Number of subjects: 216
Study 29683702 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (PE) + alcohol use disorder treatment
Number of subjects: 216
Study 29683702 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (PE) + nicotine use disorder treatment
Number of subjects: 216
Study 29683702 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model analysis
Number of subjects: 216
Study 28642081 — intervention group
Group type: COMPARATOR
Intervention: Intravenous THC administered during the Rey‐Auditory Verbal Learning Test (RAVLT) in experiment #2 (n=57).
Number of subjects: 95
Study 28642081 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered before the Rey‐Auditory Verbal Learning Test (RAVLT) in experiment #1 (n=38).
Number of subjects: 95
Study 26189203 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment (subjective and objective measures)
Number of subjects: 121
Study 26189203 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective cognitive impairment
Number of subjects: 121
Study 26189203 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective cognitive impairment (slower processing speed and poorer inhibitory control)
Number of subjects: 121
Study 26189203 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective and objective measures of cognitive impairment
Number of subjects: 121
Study 24136693 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of obesity to the problem list
Number of subjects: 497
Study 24136693 — intervention group
Group type: COMPARATOR
Intervention: No addition of obesity to the problem list (Control)
Number of subjects: 497
Study 21936683 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 61
Study 21936683 — intervention group
Group type: COMPARATOR
Intervention: Standard GP care
Number of subjects: 61
Study 18573713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16263773 — intervention group
Group type: EXPERIMENTAL
Intervention: 480 micromol x kg(‐1) x h(‐1) intravenous amino acid solution for 5 h
Number of subjects: 0
Study 16263773 — intervention group
Group type: EXPERIMENTAL
Intervention: 960 micromol x kg(‐1) x h(‐1) intravenous amino acid solution for 5 h
Number of subjects: 0
Study 16263773 — intervention group
Group type: EXPERIMENTAL
Intervention: 960 micromol x kg(‐1) x h(‐1) intravenous amino acid solution for 24 h
Number of subjects: 0
Study 16263773 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased amino acid load
Number of subjects: 0
Study 12694671 — intervention group
Group type: COMPARATOR
Intervention: Clinical staging (arm A)
Number of subjects: 61
Study 12694671 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical staging (arm B)
Number of subjects: 61
Study 12694671 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach (LAP)
Number of subjects: 61
Study 12694671 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach (EXP)
Number of subjects: 61
Study 10636142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 857
Study 10636142 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 857
Study 10636142 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 20 mg
Number of subjects: 857
Study 10636142 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 857
Study 10636142 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 80 mg
Number of subjects: 857
Study 9100037 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation with protein- and phosphorous-restricted diet
Number of subjects: 157
Study 9100037 — intervention group
Group type: COMPARATOR
Intervention: Phosphorous-load diet
Number of subjects: 157
Study 9100037 — intervention group
Group type: COMPARATOR
Intervention: Protein- and phosphorous-restricted diet without calcium supplementation
Number of subjects: 157
Study 8299406 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA treatment (20 repeated infusions of 3 grams over 5-9 weeks)
Number of subjects: 54
Study 8299406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 3106234 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas immunoglobulin (250 mg/kg body weight, intravenous route, days 3 to 13)
Number of subjects: 26
Study 3106234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Pseudomonas immunoglobulin)
Number of subjects: 26
Study 3106234 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas immunoglobulin
Number of subjects: 26
Study 29392727 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 98
Study 29392727 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 98
Study 29392727 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty
Number of subjects: 98
Study 29392727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 27267753 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI-551 (0.1-10.0 mg/kg)
Number of subjects: 28
Study 27267753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24633684 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard hygiene intervention (S)
Number of subjects: 30209
Study 24633684 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced standard hygiene intervention (ES)
Number of subjects: 30209
Study 24633684 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine body wash (CHG)
Number of subjects: 30209
Study 23901089 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 2784
Study 23901089 — intervention group
Group type: COMPARATOR
Intervention: Control (uncircumcised men)
Number of subjects: 2784
Study 19837551 — intervention group
Group type: EXPERIMENTAL
Intervention: Core decompression and implantation of a biomaterial-loaded allograft threaded cage
Number of subjects: 76
Study 19837551 — intervention group
Group type: COMPARATOR
Intervention: Core decompression
Number of subjects: 76
Study 19024525 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic docetaxel (70 mg/m2 on D2) combined with doxorubicin (40 mg/m2 on D1)
Number of subjects: 88
Study 19024525 — intervention group
Group type: COMPARATOR
Intervention: Taxotere (70 mg/m2 on D2) combined with doxorubicin (40 mg/m2 on D1)
Number of subjects: 88
Study 16487524 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12538218 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper lip bite test
Number of subjects: 300
Study 12538218 — intervention group
Group type: COMPARATOR
Intervention: Modified Mallampati test
Number of subjects: 300
Study 10547170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated interventions
Number of subjects: 1226
Study 10547170 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated interventions involving anti-infective agents
Number of subjects: 1226
Study 10547170 — intervention group
Group type: COMPARATOR
Intervention: Control group (observed patients)
Number of subjects: 1226
Study 10547170 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cost-saving interventions
Number of subjects: 1226
Study 8975568 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of opiate premedication, regional blocking, and parenteral diclophenak-Na before and after the operation
Number of subjects: 152
Study 8975568 — intervention group
Group type: COMPARATOR
Intervention: Control groups (one or several components excluded from the protocol of anesthesia)
Number of subjects: 152
Study 8975568 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive analgesia
Number of subjects: 152
Study 1809047 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 30
Study 7196167 — intervention group
Group type: EXPERIMENTAL
Intervention: halothane
Number of subjects: 48
Study 7196167 — intervention group
Group type: COMPARATOR
Intervention: fentanyl
Number of subjects: 48
Study 7196167 — intervention group
Group type: COMPARATOR
Intervention: enflurane
Number of subjects: 48
Study 31689890 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation (225 ug/day, potassium iodide tablets)
Number of subjects: 90
Study 31689890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 29331170 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced terminal disinfection with UV disinfection devices
Number of subjects: 18411
Study 29331170 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to overcome barriers to implementation
Number of subjects: 18411
Study 26385269 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 2709
Study 26385269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2709
Study 25146513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin XL 80 mg once daily
Number of subjects: 436
Study 25146513 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin IR 40 mg twice daily
Number of subjects: 436
Study 21481225 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole rye kernel bread
Number of subjects: 44